AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Amphastar Pharmaceuticals, Inc. Director's Dealing 2016

Feb 4, 2016

10216_dirs_2016-02-03_b2365122-129a-4ef0-a472-69f66d9453dc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2014-06-24

Reporting Person: Shandell Jason B. (Director, President)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3332	Direct

Footnotes

F1: The reported shares are represented by deferred stock units, or DSUs, which vest in five equal annual installments beginning on August 2, 2010.

F2: This amended Form 3 is filed to correct the amount of DSUs held by the reporting person. The prior Form 3 reported 666 DSUs. This error in column 2 of Table I also appears in subsequent Forms 4 filed through October 6, 2015.